NCT03888872

Brief Summary

The purpose of the study is to investigate the effect of high tone power therapy on neurophysiological measures and function outcome in patients with diabetic neuropathy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 12, 2019

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

March 22, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 25, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 14, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2020

Completed
Last Updated

December 1, 2022

Status Verified

November 1, 2022

Enrollment Period

1.3 years

First QC Date

March 22, 2019

Last Update Submit

November 30, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Measuring Nerve Conduction Velocity

    Neuro pack M1 EP/EMG measuring system MEB-9200/9300

    Up to 30 days

Study Arms (2)

Group I

EXPERIMENTAL

Group I (Study): will consist of 20 patients with diabetic neuropathy and will receive High tone power therapy in addition to selected physical therapy program (Wobble board training, AROM exercises for both UL \& LL, gentle manual stretching exercises for both UL \& LL and graduated gait training). for 10 sessions every other day, each session for 1.45 hours (60 minutes for HiTop and 45 minutes for selected physical therapy program).

Device: High tone power therapyOther: Selected Physical Therapy Program

Group II

EXPERIMENTAL

Group II (Control): will consist of 20 patients with diabetic neuropathy and will receive selected physical therapy program only same as group I. For 10 sessions every other day, each session for 45 minutes.

Other: Selected Physical Therapy Program

Interventions

1- High Tone Power Therapy (HiTop 191): (For group I). The high tone power therapy through using a device (HiTop 191; gbo Medizintechnik, Rimbach, Germany). The intensity of the electrical stimulation will be adjusted to a pleasant level that did not produce any pain or discomfort. Duration: 60 min (Each one electrode to both thighs to the knee, each one electrode to both thighs to the groin). Position: lying / setting, Number of sessions: 10, Frequency of sessions: 3 times per week.

Group I

Selected physical therapy program: (For both groups). 1. Wobble board training: 2. Active range of motion exercises (AROM): 3. Gentle manual stretching exercises for both UL \& LL: 4. Graduated gait training:

Group IGroup II

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Forty type II referred diabetic neuropathy patients from both genders their ages will be ranged from 40-60 years old.
  • All patients with diabetic neuropathy \> 10 years having diabetes (will be examined according to the general and specific neurological evaluation sheet for diabetic neuropathy).
  • All patients in the study should be ambulant independently.
  • All patients should be medically stable.
  • The body mass index (BMI) ranged from 20:30 Kg/m2.
  • All patients will approve and sign a consent form.

You may not qualify if:

  • Patients \< 10 years having diabetes.
  • Patients with musculoskeletal deformities and disorders.
  • Patients with psychiatric disorders or seizures.
  • Patients with visual and auditory impairment or tremors influencing balance.
  • Patients with other neuromuscular disorders.
  • Patients with BMI more than 30 kg/m2.
  • Patients with foot deformities and ulcers.
  • Patients with cognitive impairment using mini-mental state examination (MMSE).
  • Patients with lower limb operations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

October 6 University

El-Sheikh Zayed City, Giza Governorate, 1133, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer in Neurological Physical Therapy

Study Record Dates

First Submitted

March 22, 2019

First Posted

March 25, 2019

Study Start

March 12, 2019

Primary Completion

June 14, 2020

Study Completion

September 10, 2020

Last Updated

December 1, 2022

Record last verified: 2022-11

Locations